Follow

Sprint Bioscience AB

Nasdaq First North GM Stockholm (Sweden)

Sprint Bioscience is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
News
05 Apr 2023 - 09:00
1 2 3 4 5
Show

20

Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
SPRINT
SE0006343745
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Sprint Bioscience AB with ticker SPRINT
Status
Active
Currency
SEK
Segment
First North Premier
First trading date
07 Nov 2014
Private placement
Sign in to buy
Private placement
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Private placement
Sign in to buy
Exercise
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Remuneration issue
Sign in to buy
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
SPRINT
SE0006343745
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Sprint Bioscience AB with ticker SPRINT
Status
Active
Currency
SEK
Segment
First North Premier
First trading date
07 Nov 2014
Private placement
Sign in to buy
Private placement
Sign in to buy
Rights issue
Sign in to buy
Private placement
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Remuneration issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
SPRINT TO 2018/2019
SE0010833178
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO 2018/2019
Status
Archived
Currency
SEK
Segment
First North Premier
Trading period
12 Apr 2018 - 06 Feb 2019
Terms
Three (3) warrants entitles the holder to subscribe for one (1) new share in the Company for the price which correspond to seventy (70) percent of the volume weighted average price for the Company's share on Nasdaq First North Premier during the period from and with January 14, 2019 to January 25, 2019, however, a minimum of SEK 15 and a maximum of SEK 29 per share. Subscription of shares with the support of warrants will take place during the period from January 28, 2019 - February 8, 2019.
Update (28.01.2019): The subscription period for warrants of series 2018/2019: 1 begins on January 28, 2019.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
SPRINT TO1
SE0013282050
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO1
Status
Archived
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 Feb 2020
Terms
One (1) warrant of series TO1 entitles the holder to subscribe for one (1) new share in the Company for SEK 14.5 during the subscription period from February 14, 2020 - February 28, 2020.
Update (22.10.2019): The record date for obtaining free warrants in Sprint Bioscience AB is set for October 30, 2019.
Update (14.02.2020): The exercise period for warrants of series TO1 in Sprint Bioscience has begun.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
SPRINT TO2
SE0013282068
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO2
Status
Archived
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 May 2020
Terms
One (1) warrant of series TO2 entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to the volume-weighted share price on the Nasdaq First North Sweden during the period from April 27, 2020 - May 8, 2020 with a thirty (30) percent discount, but not more than SEK 16 per share. The subscription witht the support of warrants of series TO2 will take place from May 14, 2020 to May 28, 2020.
Update (22.10.2019): The record date for obtaining free warrants in Sprint Bioscience AB is set for October 30, 2019.
Update (14.05.2020): Exercise period for warrants of series TO2 2019 in Sprint Bioscience AB begins today.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
SPRINT TO4
SE0014428199
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO4
Status
Archived
Currency
SEK
Segment
First North Premier
Trading period
16 Jul 2020 - 10 Mar 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 8.25 during the subscription period from February 15, 2021 - March 14, 2021.
Update (08.07.2020): Sprint Bioscience AB announces the last day for trading with BTU and first day for trading in warrants TO 4.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
SPRINT TO5
SE0018768780
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO5
Status
Archived
Currency
SEK
Trading period
15 Dec 2022 - 26 May 2023
Terms
Two (2) warrants entitles the holder to subscribe one (1) new share for SEK 1.0 during the period May 15, 2023 - May 30, 2023.
Exercise
Sign in to buy
People
Johan Emilsson
CEO
Björn Sjöstrand
Chairman of the board
Svein Mathisen
Board member
Erik Björk
Board member
Jan-Erik Nyström
Board member
Fredrik Lehmann
Board member
Company Details
Sector
HEALTH CARE

Address
Hälsovägen 7
Zip code
141 57
City/district
Huddinge
Country
Sweden (SE)
Registration number
556789-7557
LEI code
5493006ED74WIIQOKC56
First trade date
07 Nov 2014
Registration date
28 Sep 2009
Short name
SPRINT

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More